FDA.reportPublic FDA data

SALMETEROL XINAFOATE

Substance profile for UNII 6EW8Q962A5, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SALMETEROL XINAFOATE
Structure render from PubChem CID 56801

Substance Identity#

UNII
6EW8Q962A5
Preferred term
SALMETEROL XINAFOATE
Registry number
94749-08-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C25H37NO4.C11H8O3
Chemical structure for SALMETEROL XINAFOATE
Structure render from PubChem CID 56801

Chemical And Database Identifiers#

SMILES
OC(=O)C1=CC=C2C=CC=CC2=C1O.OCC3=C(O)C=CC(=C3)C(O)CNCCCCCCOCCCCC4=CC=CC=C4
RxCUI
72616
PubChem
56801
NCIt
C61935
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound56801https://pubchem.ncbi.nlm.nih.gov/compound/56801
RxNorm72616https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=72616
NCI ThesaurusC61935https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61935
FDA Substance Registration System6EW8Q962A5https://precision.fda.gov/uniisearch/srs/unii/6EW8Q962A5

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5These highlights do not include all the information needed to use SEREVENT DISKUS safely and effectively. See full prescribing information for SEREVENT DISKUS. SEREVENT DISKUS (salmeterol xinafoate inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 19942
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS. ADVAIR DISKUS 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 500/50 (fluticasone propionate 500 mcg and salmeterol 50 mcg inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 20005
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS. ADVAIR DISKUS 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 500/50 (fluticasone propionate 500 mcg and salmeterol 50 mcg inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 20001
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS. ADVAIR DISKUS 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 500/50 (fluticasone propionate 500 mcg and salmeterol 50 mcg inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 20001
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS. ADVAIR DISKUS 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 500/50 (fluticasone propionate 500 mcg and salmeterol 50 mcg inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 20001
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5These highlights do not include all the information needed to use ADVAIR DISKUS safely and effectively. See full prescribing information for ADVAIR DISKUS. ADVAIR DISKUS 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) ADVAIR DISKUS 500/50 (fluticasone propionate 500 mcg and salmeterol 50 mcg inhalation powder) FOR ORAL INHALATION Initial U.S. Approval: 20001
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5ADVAIR DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3614
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5ADVAIR HFA (FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE) AEROSOL, METERED [GLAXOSMITHKLINE LLC]20
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5SEREVENT DISKUS (SALMETEROL XINAFOATE) POWDER, METERED [GLAXOSMITHKLINE LLC]17
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5ADVAIR DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [GLAXOSMITHKLINE LLC]15
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5ADVAIRDISKUS DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [REMEDYREPACK INC. ]1
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5ADVAIRDISKUS DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [REMEDYREPACK INC. ]1
SALMETEROL XINAFOATEACTIVE INGREDIENT6EW8Q962A5ADVAIRDISKUS DISKUS (FLUTICASONE PROPIONATE AND SALMETEROL) POWDER [REMEDYREPACK INC. ]1